Upload
others
View
5
Download
0
Embed Size (px)
Citation preview
(1) LABoratoire d’Étude des Résidus et Contaminants dans les Aliments (LABERCA) USC INRA 1329, Oniris, LUNAM Université, BP 50707, 44307 Nantes Cedex 3, France
Fax : +33 (0)2 40 68 78 78 - Tél : +33 (0)2 40 68 78 80 [email protected] - www.laberca.org
Poster presented at the EuroResidue VIIth Conference, Egmond aan Zee, The Nertherlands, 14th-16th May 2012.
Introduction Experimental
Results and discussion
Conclusion
(2) Banat’s University of Agriculture and Veterinary Medecine, Timisoara, Romania
(3) LUNAM Université, Oniris, Centre Hospitalier Vétérinaire, Atlanpole - La Chantrerie, BP 50707, Nantes F-44307, France
Sandrine Rochereau1, Emmanuelle Bichon1, Frédérique Courant1, Fabrice Monteau1, Stéphanie Prévost1, Flavia Hanganu1,2, Nora Cesbron3, Gaud Dervilly-Pinel1, Bruno Le Bizec1
QUANTIFICATION OF ESTROGENS AT PPT LEVELS IN BOVINE PLASMA BY
MOLECULARLY IMPRINTED SOLID PHASE EXTRACTION AND GC-MS/MS ANALYSIS
The use of anabolic agents in food producing animals has been prohibited
within the EU since 1988 (96/22/EC directive). In particular, the control of
natural steroid hormones administration in cattle still represent a difficult
challenge because of the high variability observed for endogenous levels of
such hormones, in relation with inter-individual polymorphisms originating
from genetic, environmental, age... Nevertheless, in 1989, the EU has
established a threshold for 17-estradiol at 40 pg mL-1 in plasma or serum of
bovine animals below 2 years old, above which a sample has to be considered
as suspect. Therefore, a screening strategy allowing pointing out estradiol
administration has been investigated through monitoring low ppt levels of
estrogens in plasma. The purification is based on molecular imprinted
polymer (MIP) is proposed here for the analysis of 17-estradiol (E2), 17-
estradiol (E2) and estrone (E1) by GC-EI-MS/MS after TMS derivatisation.
The efficiency of the developed method has been successfully assessed on samples
collected on incurred samples. The MIP selectivity was assessed and adapted
according to the expected purification quality of the biological extract. This
method will be implemented for on an experimental plan in 2012 to validate its
robustness and to adjust the compliant threshold for a future screening method of
estradiol in bovine serum. This strategy was then implemented on urine to assess
steroid purification efficiency on MIP-SPE before gas chromatography-combustion-
isotope ratio mass spectrometry (GC-C-IRMS) analysis to confirm the origin of
target natural steroids. A new protocol was then based on an efficient combination
between MIP packed in chromatographic column and preparative SFC to obtain an
excellent purification (E. Bichon, 2012).
Animal experiment
The animal experiment was conducted in agreement with animal welfare rules. After an
acclimation period, each two calves (6327 and 7669) received one intramuscular
injection of 30 mg of estradiol diluted in sesame oil at day 0. Blood samples were
collected from 3 days before administration (Day-3) and 5 hours, 1, 2, 6 and 7 days after
administration respectively called D0+5h, D1, D2, D6 and D7. The sera were obtained
after blood centrifugation at 3000 rpm for 10 min and were stored at -18°C.
Chemicals
Standard reference steroids were purchased from Steraloids (Wilton, NY, USA) and
Cambridge Isotope Laboratories (Andover, MA, USA). MIPs (AFFINIMIP-estradiol) were
from Polyintell (Val de Reuil, France). β-glucuronidase was provided by Roche (Rosny
sous Bois, France). N,O-bis(trimethylsilyl)-trifluoroacetamide (BSTFA) was from Fluka
(Buchs, Switzerland). All solvents and reagents were of analytical grade quality and
provided by Carlo Erba (Val-de-Reuil, France).
Sample preparation
Serum samples (2 mL) were spiked with 40 pg 17β-estradiol-d3 (internal standard). Two
milliliters of 0.8 M acetate buffer (pH 6.8) and 100 µL β-glucuronidase were added.
Hydrolysis was performed overnight at 37°C and samples were centrifuged at 4000 rpm
for 10 min. The upper layer was loaded onto an AFFINIMIP-estradiol previously
conditioned with 4 mL methanol, 4 mL acetonitrile and 4 mL water. Two washing steps
with 5 mL water and 5 mL water / acetonitrile (60:40,v/v) preceded elution. The
molecules of interest were eluted with 3 mL of methanol. Extracts were evaporated to
dryness and estrogens were derivatised 40 min at 60°C with BSTFA before to be injected
onto a GC-MS/MS (2 µL).
GC-MS/MS instrument
Estrogens’ determination was carried out by GC-MS/MS in electronic impact. An Agilent
7890 gas chromatograph was coupled to a triple quadripole mass analyser Agilent 7000
(Agilent Technologies, Santa Clara, USA). GC column was a 15 m × 0.25 mm × 0.10 µm,
RTX-1614 (Restek, Lisses, France). The gradient of temperature was set from 80°C to
320°C (15°C.min-1). Two transitions were monitored per compound.
GC-MS/MS
Preparative HPLC (1)
PFB Derivatisation(1)
LLE Pentane (1)
copolymeric SPE (1)
Enzymatic hydrolysis
LLE ether (1)
SiOH SPE (1)
MIP: estradiol
(AFFINIMIP®, Polyintell)
2 mL bovine plasma
TMS Derivatisation
Fig 1: New sample preparation with MIP purification to replace the approach of Courant et al (2010)
Analytical results
The quantification can be performed at concentration level as low as 10 pg mL-1 with two
diagnostic signals (MRM transition) monitored per analyte. Consequently, the target
threshold at 40 pg mL-1 can now be monitored with a rapid and efficient sample
preparation and a classical ionisation in electronic impact with TMS derivatisation (Fig 2).
Concentrations in the incurred samples
The quantification of αE2, βE2 and E1 was performed in all plasma samples collected
from the animal experimentation. The results are presented in Figure 3. The apex of the
kinetic corresponds to samples collected 5 hours after administration, when the
concentrations reaches 1 ppb. In addition, the plasma samples, taken between day 0+5h
and day 2 after administration, present βE2 concentrations above the proposed threshold
(i.e. 40 ppt). They can then directly been concluded as suspicious.
Moreover, the sensitivity of this method allows the detection, identification and
quantification of estrogens during all the experimentation procedure, i.e. during the
seven days after administration. During this week after treatment, the return to the basal
values is achieved only at D7. In conclusion, with this very efficient method, we may
consider suspicious samples until 7 days after administration. This strategy has to be
confirmed with additional plasma samples (coming from untreated animals with ages,
different sexes and races). All these results show the potentiality of this method to be
used for the screening of estrogens in bovine plasma.
Blank plasma 10 ppt 40 ppt 100 ppt
17-estradiol-d3
419>285
17/-estradiol
416>129
17/-estradiol
416>285
Fig 2: MRM chromatograms obtained from fortified calves’ plasma samples at 0, 10, 40 and 100 pg.mL-1 with 17α-estradiol, 17β-estradiol and estrone.
0
500
1000
1500
2000
2500
0 2 4 6 8
Co
nce
ntr
atio
n (
pg.
mL-1
)
Days
αE2
βE2
E1
0
20
40
60
80
100
120
0 2 4 6 8
Co
nce
ntr
atio
n (
pg.
mL-1
)
Days
αE2
βE2
E1
Fig 3: Plasmatic concentration of 17-, 17-estradiol and estrone after estradiol one IM injection (30mg).
References
E. Bichon, S. Anizan, S. Prevost, L. Sérée, M. Doué, P. Sitthisack, D. Di Nardo, T. Duval, F. Monteau, J.-P. Antignac and B. Le Bizec. (2012) Strategies todetect natural steroids misuse in cattle : the steroidomic powerful screening and GC-C-IRMS for confirmation. Proceeding EuroResidue VII Conference.
Council Directive 96/22/EC concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of beta-agonists, and repealing Directives 81/602/EEC, 88/146/EEC and 88/299/EEC. Off. J. Eur. Commun. 1996;L125:3.
F. Courant, L. Aksglaede, J.-P. Antignac, F. Monteau, K. Sorensen, A.-M. Andersson, N. E. Skakkebaek, A. Juul, B. Le Bizec. (2010) Assessment of Circulating Sex Steroid Levels in Prepubertal and Pubertal Boys and Girls by a Novel Ultrasensitive Gas Chromatography-Tandem Mass Spectrometry Method. J Clin Endocrinol Metab, 95(1):82–92